Home> Products> bipolar disorder management with quetiapine

{ "products": [ { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c15c3d89239081848a6ac", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ZIPRANODE 40 ", "description": "ZIPRANODE 40 \nZiprasidone Capsules (40mg)\nIntroduction:\n\nZIPRANODE 40 contains Ziprasidone, an atypical antipsychotic medication, at a dosage strength of 40mg. It is designed for the treatment of schizophrenia and the manic or mixed episodes associated with bipolar disorder. ZIPRANODE 40 works by modulating the activity of neurotransmitters in the brain, helping to stabilize mood and reduce psychotic symptoms.\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nZIPRANODE 40 is effective in treating the symptoms of schizophrenia, including hallucinations, delusions, thought disorders, and social withdrawal. It helps restore balance to neurotransmitters in the brain, particularly dopamine and serotonin.\nMood Stabilization:\n\nZiprasidone is also used to manage manic or mixed episodes in bipolar disorder. It helps control mood swings, reducing the intensity and frequency of manic episodes and helping patients maintain a stable mood.\nDual Mechanism of Action:\n\nZIPRANODE 40 acts as both a serotonin and dopamine receptor antagonist. This dual mechanism of action helps in effectively managing a broad range of symptoms associated with schizophrenia and bipolar disorder.\nFavorable Side Effect Profile:\n\nCompared to other antipsychotics, Ziprasidone has a lower risk of causing weight gain and metabolic disturbances, making it a preferred option for long-term management of psychiatric conditions.\nDosage and Administration:\n\nInitial Dosage for Schizophrenia:\n\nThe recommended starting dose of ZIPRANODE 40 for adults with schizophrenia is 20mg twice daily. The dose can be increased gradually based on the patient’s response and tolerability, up to a maximum of 80mg twice daily.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of manic or mixed episodes in bipolar disorder, the initial dose is 40mg twice daily. The dose can be adjusted based on clinical response, with a usual range of 40-80mg twice daily.\nAdministration Instructions:\n\nZIPRANODE 40 capsules should be taken orally with food to enhance absorption. Swallow the capsules whole with water. Do not crush or chew the capsules.\nContinued Monitoring:\n\nRegular monitoring of symptoms, side effects, and overall health is essential during ZIPRANODE 40 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/zipranode-40-133982", "price": 185.0, "discountamount": 55.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "80mg", "40mg", "food", "EMAIL", "water", "brain", "adults", "balance", "maximum", "activity", "patients", "Benefits", "serotonin", "intensity", "delusions", "treatment", "frequency", "absorption", "lower risk", "stable mood", "usual range", "broad range", "information", "weight gain", "mood swings", "initial dose", "sterisonline", "tolerability", "Key Features", "side effects", "sterispharma", "Introduction", "starting dose", "schizophrenia", "CALL/WHATSAPP", "hallucinations", "patient safety", "manic episodes", "overall health", "mixed episodes", "Dual Mechanism", "Initial Dosage", "dosage strength", "bipolar disorder", "thought disorders", "social withdrawal", "clinical response", "ZIPRANODE 40 acts", "neurotransmitters", "Mood Stabilization", "psychotic symptoms", "Regular monitoring", "Antipsychotic Action", "therapeutic efficacy", "ZIPRANODE 40 therapy", "Continued Monitoring", "long-term management", "Ziprasidone Capsules", "other antipsychotics", "ZIPRANODE 40 capsules", "psychiatric conditions", "metabolic disturbances", "Administration Instructions", "dopamine receptor antagonist", "Favorable Side Effect Profile", "atypical antipsychotic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1913, "imageuri": "https://productimages.withfloats.com/actual/667d1364c134db5b38ba45ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1364c134db5b38ba45ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T10:04:51.679Z", "updatedon": "2024-06-29T12:17:40.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/zipranode-40-/1913", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ZIPRANODE 40 ", "category": "NEUROLOGY RANGE", "tags": [ "Ziprasidone Capsules (40mg)", "ZIPRANODE 40", "", "ziprasidone side effects", "ziprasidone warnings", "ziprasidone side effects weight loss", "ziprasidone mechanism of action" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0efb162db0236048ba8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 300 ", "description": "VALPOTREAT CR 300 \nSodium Valproate CR 300 mg\nIntroduction:\n\nVALPOTREAT CR 300 contains Sodium Valproate, a highly effective anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 300mg, VALPOTREAT CR 300 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 300 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 300 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 300 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 300 for adults typically starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 300 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-300-134219", "price": 78.0, "discountamount": 23.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "time", "food", "need", "EMAIL", "brain", "water", "adults", "option", "quality", "patients", "Benefits", "severity", "epilepsy", "adherence", "two doses", "frequency", "medication", "information", "mood swings", "Introduction", "initial dose", "sterisonline", "sterispharma", "tolerability", "GABA) levels", "Key Features", "various types", "CALL/WHATSAPP", "overall health", "Initial Dosage", "patient safety", "mood stability", "manic episodes", "steady release", "liver function", "mood stabilizer", "dosage strength", "symptom control", "frequent dosing", "bipolar disorder", "absence seizures", "seizure episodes", "neuronal activity", "treatment regimen", "clinical response", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "long-term management", "therapeutic efficacy", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "effective anticonvulsant", "complex partial seizures", "typical maintenance dose", "favorable safety profile", "VALPOTREAT CR 300 therapy", "VALPOTREAT CR 300 tablets", "Administration Instructions", "gastrointestinal discomfort", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1908, "imageuri": "https://productimages.withfloats.com/actual/666c0efef068be46bdec91c1.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0efef068be46bdec91c1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:35:55.629Z", "updatedon": "2024-06-29T12:22:31.565Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-300-/1908", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 300 mg", "VALPOTREAT CR 300", "", "VALPOTREAT CR 300", "valprol cr 300 side effects", "valprol cr 300 generic name", "valprol cr 300 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0dc4a20cb421407442bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 200 ", "description": "VALPOTREAT CR 200 \nSodium Valproate CR 200 mg\nIntroduction:\n\nVALPOTREAT CR 200 contains Sodium Valproate, a widely used anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 200mg, VALPOTREAT CR 200 is designed to provide sustained therapeutic effects for the management of epilepsy and bipolar disorder, improving the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 200 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer in the treatment of bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 200 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This helps in achieving better symptom control and improving adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 200 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 200 for adults typically starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 200 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 200 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-200-134218", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "need", "life", "GABA", "food", "time", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "severity", "epilepsy", "Benefits", "patients", "adherence", "frequency", "two doses", "medication", "information", "mood swings", "Introduction", "initial dose", "Key Features", "tolerability", "sterispharma", "sterisonline", "CALL/WHATSAPP", "various types", "patient safety", "Initial Dosage", "overall health", "steady release", "liver function", "mood stability", "manic episodes", "dosage strength", "mood stabilizer", "symptom control", "frequent dosing", "absence seizures", "bipolar disorder", "seizure episodes", "clinical response", "treatment regimen", "neuronal activity", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "therapeutic efficacy", "long-term management", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "consistent blood levels", "gamma-aminobutyric acid", "typical maintenance dose", "complex partial seizures", "favorable safety profile", "VALPOTREAT CR 200 therapy", "VALPOTREAT CR 200 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1907, "imageuri": "https://productimages.withfloats.com/actual/666c0dc8c9162f54a15a020e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0dc8c9162f54a15a020e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:30:44.587Z", "updatedon": "2024-06-26T09:16:37.475Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-200-/1907", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "VALPOTREAT CR 200", "Sodium Valproate CR 200 mg", "valpotreat cr 200 uses in hindi", "valprol cr 200 uses in hindi", "valpotreat cr 200 expiry date", "valpotreat" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c09b805b00e1ad41ca790", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 50 ", "description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\n\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-50-133634", "price": 99.0, "discountamount": 29.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "50mg", "25mg", "risk", "EMAIL", "night", "option", "adults", "anxiety", "quality", "symptoms", "severity", "50-100mg", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "TP MATE 50 therapy", "glutamate activity", "TP MATE 50 tablets", "migraine prevention", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "versatile anticonvulsant", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1905, "imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:13:28.046Z", "updatedon": "2024-06-26T06:01:34.175Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-50-/1905", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TP MATE 50", "", "Topiramate (50mg)", "topiramate uses", "topiramate 50 mg", "topiramate side effects", "topiramate side effects weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c08e7c91739182c9574b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 100 ", "description": "TP MATE 100 \nTopiramate (100mg)\nIntroduction:\n\nTP MATE 100 contains Topiramate, a broad-spectrum anticonvulsant and migraine prophylactic medication. With a dosage strength of 100mg, TP MATE 100 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 100 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 100 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 100 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 100 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 100 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 100 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 100 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-100-133633", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "25mg", "risk", "50mg", "EMAIL", "night", "100mg", "option", "adults", "anxiety", "quality", "symptoms", "severity", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "glutamate activity", "migraine prevention", "TP MATE 100 therapy", "TP MATE 100 tablets", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "broad-spectrum anticonvulsant", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1904, "imageuri": "https://productimages.withfloats.com/actual/666c08eb0b4fc76a99a41986.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c08eb0b4fc76a99a41986.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:09:59.43Z", "updatedon": "2024-06-26T06:09:24.07Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-100-/1904", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "tp mate 100 tablet price", "topiramate side effects weight loss", "topiramate side effects", "tp mate 100 tablet in hindi language" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be30aa20cb42140743ca6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERITIME PLUS ", "description": "RISPERITIME PLUS \nRisperidone (2mg), Trihexyphenidyl (2mg)\nIntroduction:\n\nRisperitime Plus is a combination medication containing Risperidone (2mg) and Trihexyphenidyl (2mg), designed to offer comprehensive management for psychiatric disorders. This dual-action formula targets both the symptoms of mental health conditions and the side effects associated with antipsychotic treatments, providing a balanced approach to patient care.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nRisperidone: As a second-generation antipsychotic, Risperidone effectively antagonizes dopamine and serotonin receptors. This action helps mitigate symptoms such as hallucinations, delusions, and disorganized thinking, common in schizophrenia and bipolar disorder.\nMood Stabilization:\n\nRisperidone also aids in stabilizing mood swings in bipolar disorder, reducing the severity of manic episodes and preventing depressive relapses. This contributes to overall emotional balance and improved quality of life.\nManagement of Side Effects:\n\nTrihexyphenidyl: An anticholinergic agent, Trihexyphenidyl is included to manage extrapyramidal symptoms (EPS) caused by antipsychotic medications. It helps alleviate symptoms such as muscle stiffness, tremors, and restlessness, which are side effects of Risperidone and other antipsychotics.\nBehavioral and Cognitive Benefits:\n\nRisperitime Plus addresses behavioral issues such as aggression, agitation, and irritability, particularly in conditions like autism spectrum disorders and dementia-related behavioral disturbances.\nIt may also offer cognitive enhancements, improving attention, executive function, and overall cognitive performance in certain patients.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Risperitime Plus is 2mg Risperidone and 2mg Trihexyphenidyl taken orally once daily. Dosage adjustments should be based on clinical response and tolerability.\nAdministration Instructions:\nSwallow the tablets whole with water, with or without food. Consistency in dosing time each day is important for maintaining therapeutic levels.\nTitration and Maintenance:\nHealthcare providers may adjust the dosage gradually to achieve optimal symptom control while minimizing side effects. Maintenance doses are personalized to each patient's needs and treatment goals.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/risperitime-plus-134326", "price": 65.0, "discountamount": 19.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "EPS", "food", "life", "EMAIL", "needs", "water", "dosing", "product", "quality", "tablets", "tremors", "dopamine", "severity", "patients", "delusions", "attention", "Titration", "agitation", "aggression", "mood swings", "Consistency", "information", "restlessness", "irritability", "Introduction", "tolerability", "sterispharma", "sterisonline", "patient care", "side effects", "Key Features", "schizophrenia", "starting dose", "CALL/WHATSAPP", "manic episodes", "hallucinations", "Initial Dosage", "2mg Risperidone", "treatment goals", "RISPERITIME PLUS", "muscle stiffness", "bipolar disorder", "Maintenance doses", "clinical response", "behavioral issues", "balanced approach", "Dosage adjustments", "executive function", "therapeutic levels", "Cognitive Benefits", "Mood Stabilization", "dual-action formula", "serotonin receptors", "depressive relapses", "2mg Trihexyphenidyl", "other antipsychotics", "Healthcare providers", "disorganized thinking", "anticholinergic agent", "psychiatric disorders", "combination medication", "Antipsychotic Efficacy", "cognitive enhancements", "extrapyramidal symptoms", "optimal symptom control", "antipsychotic treatments", "comprehensive management", "mental health conditions", "autism spectrum disorders", "antipsychotic medications", "overall emotional balance", "Administration Instructions", "overall cognitive performance", "second-generation antipsychotic", "dementia-related behavioral disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1892, "imageuri": "https://productimages.withfloats.com/actual/666be30d117f82c50b0c8762.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/666be30d117f82c50b0c8762.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:28:26.525Z", "updatedon": "2024-06-26T07:08:54.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/risperitime-plus-/1892", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERITIME PLUS ", "category": "NEUROLOGY RANGE", "tags": [ "Trihexyphenidyl (2mg)", "Risperidone (2mg)", "RISPERITIME PLUS", "", "risdone plus side effects", "risdone plus dosage", "risperidone and trihexyphenidyl tablets uses in hi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac8a1ca84cd189c25c6ce", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OLANZPRIME FOX 5/20 ", "description": "OLANZPRIME FOX 5/20 \nFluoxetine (20mg) & Olanzapine (5mg)\nIntroduction:\n\nOLANZPRIME FOX 5/20 is a combination medication containing Fluoxetine (20 mg) and Olanzapine (5 mg), designed to treat depressive episodes associated with bipolar disorder and treatment-resistant depression. This combination harnesses the antidepressant effects of Fluoxetine and the antipsychotic properties of Olanzapine to provide comprehensive management of these complex conditions.\n\n\nOLANZPRIME FOX 5/20: Effective Combination Therapy for Depression and Bipolar Disorder\n\nFluoxetine (20 mg) & Olanzapine (5 mg)\n\nIntroduction:\n\nOLANZPRIME FOX 5/20 is a combination medication containing Fluoxetine (20 mg) and Olanzapine (5 mg), designed to treat depressive episodes associated with bipolar disorder and treatment-resistant depression. This combination harnesses the antidepressant effects of Fluoxetine and the antipsychotic properties of Olanzapine to provide comprehensive management of these complex conditions.\n\nKey Features and Benefits:\n\nDual Action: The combination of Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), and Olanzapine, an atypical antipsychotic, targets both mood stabilization and depression, providing a synergistic effect.\nDepression Treatment: Fluoxetine effectively treats major depressive episodes by increasing serotonin levels in the brain, improving mood, and alleviating depressive symptoms.\nBipolar Disorder Management: Olanzapine helps manage manic and mixed episodes associated with bipolar disorder, reducing symptoms such as mood swings, agitation, and irritability.\nComprehensive Symptom Relief: The combination addresses a broad spectrum of symptoms, including anxiety, agitation, and cognitive disturbances, offering holistic treatment for patients with complex mental health needs.\nProven Efficacy: The combined therapy of Fluoxetine and Olanzapine is well-established, with clinical evidence supporting its effectiveness in treating bipolar depression and treatment-resistant depression.Dosage and Administration:\n\nInitial Dosage: The typical starting dose of OLANZPRIME FOX 5/20 is one tablet taken once daily, usually in the evening due to Olanzapine’s sedative effects.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment and the severity of symptoms. Regular follow-ups are necessary to monitor effectiveness and adjust the dosage accordingly.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take OLANZPRIME FOX 5/20 at the same time each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/olanzprime-fox-5-20-134396", "price": 60.0, "discountamount": 10.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SSRI", "food", "EMAIL", "brain", "manic", "water", "product", "anxiety", "evening", "Benefits", "patients", "severity", "response", "same time", "agitation", "Fluoxetine", "Olanzapine", "one tablet", "mood swings", "information", "Dual Action", "bloodstream", "sterisonline", "sterispharma", "irritability", "Introduction", "Key Features", "effectiveness", "CALL/WHATSAPP", "Initial Dosage", "broad spectrum", "Administration", "OLANZPRIME FOX", "mixed episodes", "Proven Efficacy", "sedative effects", "serotonin levels", "combined therapy", "clinical evidence", "mood stabilization", "Maintenance Dosage", "holistic treatment", "bipolar depression", "Regular follow-ups", "synergistic effect", "complex conditions", "depressive symptoms", "healthcare provider", "Depression Treatment", "typical starting dose", "combination medication", "cognitive disturbances", "atypical antipsychotic", "antidepressant effects", "antipsychotic properties", "comprehensive management", "major depressive episodes", "Bipolar Disorder Management", "complex mental health needs", "consistent medication levels", "Comprehensive Symptom Relief", "Effective Combination Therapy", "treatment-resistant depression", "selective serotonin reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1866, "imageuri": "https://productimages.withfloats.com/actual/667d224c1657b0caada54cc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d224c1657b0caada54cc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:23:29.686Z", "updatedon": "2024-06-27T08:26:51.772Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/olanzprime-fox-5-20-/1866", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME FOX 5/20 ", "category": "NEUROLOGY RANGE", "tags": [ "olanzprime fox 5/20 mg price", "olanzprime fox 5/20 mg", "olanzapine 5 mg fluoxetine 20 mg", "olanzapine side effects long-term" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }